Subjects with lower circulating LDL cholesterol due to variants in the activity of 3-hydroxy-3-methylglutaryl-CoA reductase were characterized by higher glucose levels, increased weight, and elevated risk for type 2 diabetes mellitus [43]. The gene discussed is HMGCR; the disease is type 2 diabetes mellitus.